Stock AKYA AKOYA BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Akoya Biosciences, Inc.

Equities

AKYA

US00974H1041

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-20 EDT 		5-day change 1st Jan Change
2.81 USD -1.40% Intraday chart for Akoya Biosciences, Inc. -31.80% -42.42%
05-15 Piper Sandler Cuts Akoya Biosciences Price Target to $6 From $8, Maintains Overweight Rating MT
05-14 Top Midday Decliners MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Top Midday Decliners
MT
Top Premarket Decliners
MT
Exchange-Traded Funds Mixed, Equity Futures Higher Pre-Bell Tuesday Ahead of Powell Speech
MT
Akoya Biosciences Sinks Over 30% in Late-Hours Activity Monday as Q1 Sales Miss Capital IQ Estimate
MT
Earnings Flash (AKYA) AKOYA BIOSCIENCES Reports Q1 Revenue $18.4M, vs. Street Est of $24.3M
MT
Akoya Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Akoya Biosciences, Inc. and NeraCare Enters into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients
CI
Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts
CI
Akoya Biosciences and Shanghai KR Pharmtech Announces Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows
CI
Akoya Biosciences Showcases Spatial Biology 2.0 Solutions At AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale
CI
Akoya Biosciences, Inc. Provides Revenue Guidance for the Full Year 2024
CI
Earnings Flash (AKYA) AKOYA BIOSCIENCES Posts Q4 Revenue $26.5M, vs. Street Est of $26.1M
MT
Akoya Biosciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
North American Morning Briefing : Stock Futures -2-
DJ
Akoya Biosciences Shares Jump on 2024 Outlook, Thermo Fisher Deal
DJ
Akoya Biosciences Expects 20% Revenue Growth in 2024; Shares Gain Premarket
MT
Akoya Biosciences Unveils Algorithm for Integration of Spatial, Single-Cell Data; Shares Jump Premarket
MT
Akoya Biosciences Deploys the Maxfuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory At Stanford University for Multiomic Integration of Spatial and Single-Cell Data on the Enable Medicine Platform
CI
Akoya Biosciences, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2023 and for the Fiscal Year 2024
CI
Akoya Biosciences, Inc. and Thermo Fisher Scientific, Inc. Announce License and Distribution Agreement to Deliver Spatial Multiomics Workflow
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AKYA Stock
  4. News Akoya Biosciences, Inc.
  5. Highlights
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW